collaborators

6 papers

stat.ME2026

Empirical Simulation of Survival and Mixed-Type Data for Clinical Trial Design

Yao Chen, Jiren Sun, Yuxin Ding +2

Simulating realistic time-to-event data is essential for planning and evaluating complex clinical trial designs. Conventional approaches often sample event times from parametric fa…

stat.ME2026

Capturing Cumulative Disease Burden in Chronic Kidney Disease Outcome Trials: Area Under the Curve and Restricted Mean Time in Favor of Treatment Beyond Conventional Time-to-First Analysis

Jiren Sun, Tuo Wang, Yu Du

Chronic kidney disease (CKD) affects millions worldwide and progresses irreversibly through stages culminating in end-stage renal disease (ESRD) and death. Outcome trials in CKD tr…

stat.ME2026

An Empirical Method for Analyzing Count Data

Jiren Sun, Linda Amoafo, Yongming Qu

Count endpoints are common in clinical trials, particularly for recurrent events such as hypoglycemia. When interest centers on comparing overall event rates between treatment grou…

stat.ME2025

Inverse Probability Weighting for Recurrent Event Models

Jiren Sun, Tobias Mutze, Richard Cook +1

Recurrent events are common and important clinical trial endpoints in many disease areas, e.g., cardiovascular hospitalizations in heart failure, relapses in multiple sclerosis, or…

stat.ME2025

Improve the Precision of Area Under the Curve Estimation for Recurrent Events Through Covariate Adjustment

Jiren Sun, Tuo Wang, Yanyao Yi +3

The area under the curve (AUC) of the mean cumulative function (MCF) has recently been introduced as a novel estimand for evaluating treatment effects in recurrent event settings,…

stat.ME2025

On the Proportional Principal Stratum Hazards Model

Jiren Sun, Thomas D. Cook

In clinical trials involving both mortality and morbidity, an active treatment can influence the observed risk of the first non-fatal event either directly, through its effect on t…